Wall Street analysts expect Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get Rating) to post revenue of $159.10 million for the current fiscal quarter, according to Zacks. Five analysts provided earnings estimates for Sabra Health Care REIT. The lowest sales estimate is $156.30 million and the highest is $161.40 million. Sabra Health Care REIT reported sales of $152.93 million in the same quarter last year, suggesting a positive year-over-year growth rate of 4%. The company is expected to release its next quarterly earnings report on Monday, January 1.
On average, analysts expect Sabra Health Care REIT to report revenue of $643.48 million for the current year, with estimates ranging from $633.70 to $655.40 million. . For the next fiscal year, analysts expect the company to post sales of $660.64 million, with estimates ranging from $635.15 million to $693.90 million. Zacks’ sales calculations are an average average based on a survey of sell-side analysts who provide coverage for Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) last reported quarterly earnings data on Wednesday, May 4. The real estate investment trust reported earnings per share of $0.18 for the quarter, beating the consensus estimate of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. In the same quarter a year earlier, the company posted earnings per share of $0.39.
SBRA has been the subject of several recent research reports. Capital One Financial launched coverage on Sabra Health Care REIT in a report on Friday. They set an “equal weight” rating and a price target of $15.50 for the company. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered its price target for the stock from $16.00 to $15.00 in a Wednesday, May 25 report. Credit Suisse Group raised its price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a Monday, April 4 research report. StockNews.com began covering Sabra Health Care REIT in a research report on Thursday, March 31. They set a “holding” rating for the company. Finally, Bank of America downgraded Sabra Health Care REIT from an “underperforming” rating to a “neutral” rating and set a target price of $15.00 for the company in a research report on Friday, March 11. . Seven equity research analysts gave the stock a hold rating and five gave the company a buy rating. Based on data from MarketBeat, Sabra Health Care REIT has a consensus rating of “Hold” and a consensus price target of $15.95.
NASDAQ:SBRA shares opened at $13.49 on Tuesday. The stock has a market capitalization of $3.12 billion, a P/E ratio of -27.53 and a beta of 1.42. Sabra Health Care REIT has a 1-year minimum of $11.44 and a 1-year maximum of $19.01. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt ratio of 0.70. The company has a 50-day moving average price of $13.24 and a two-hundred-day moving average price of $13.44.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31. Investors of record on Monday, May 16 received a dividend of $0.30. The ex-dividend date was Friday, May 13. This represents an annualized dividend of $1.20 and a dividend yield of 8.90%. Sabra Health Care REIT’s dividend payout ratio is currently -244.89%.
Several institutional investors and hedge funds have recently changed their stock holdings. Voya Investment Management LLC increased its position in shares of Sabra Health Care REIT by 0.4% in the third quarter. Voya Investment Management LLC now owns 187,382 shares of the real estate investment trust worth $2,758,000 after purchasing an additional 734 shares during the period. US Bancorp DE increased its position in shares of Sabra Health Care REIT by 17.7% in the third quarter. US Bancorp DE now owns 5,533 shares of the real estate investment trust worth $81,000 after purchasing an additional 831 shares during the period. The Alaska State Department of Revenue increased its position in Sabra Health Care REIT shares by 0.6% in the fourth quarter. The Alaska State Department of Revenue now owns 149,160 shares of the real estate investment trust worth $2,019,000 after purchasing 897 additional shares during the period. Cetera Investment Advisers increased its stake in Sabra Health Care REIT by 1.2% in Q1. Cetera Investment Advisers now owns 80,608 shares of the real estate investment trust worth $1,200,000 after acquiring 919 additional shares in the last quarter. Finally, Xponance Inc. increased its stake in Sabra Health Care REIT by 2.9% in the 4th quarter. Xponance Inc. now owns 34,248 shares of the real estate investment trust worth $464,000 after acquiring 957 additional shares in the last quarter. Institutional investors and hedge funds hold 91.61% of the company’s shares.
Sabra Health Care REIT Company Profile (Get an evaluation)
As of September 30, 2020, Sabra’s investment portfolio comprised 425 properties held for investment (composed of (i) 287 skilled nursing/transitional care facilities, (ii) 64 retirement homes (Senior Housing – Leased), (iii) 47 Senior Residences operated by third-party property managers under property management contracts (Senior Housing – Managed) and (iv) 27 Specialized Hospitals and Other Establishments), an asset held for the sale, one investment in direct leasing, 19 investments in loans receivable (including (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six investments in preferred shares and one investment in an unconsolidated joint venture that owns 158 seniors’ residences – managed communities.
Get a Free Copy of Zacks Research Report on Sabra Health Care REIT (SBRA)
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
Get news and reviews for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s free daily email newsletter.